Related Experiment Video
Updated: Jul 3, 2026

Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons
Published on: November 6, 2017
Differential roles of NMDA receptor subtypes in ischemic neuronal cell death and ischemic tolerance
Min Chen1, Ting-Jia Lu, Xiao-Jing Chen
1Institute of Neuroscience, State Key Laboratory of Neuroscience, Shanghai, China.
Background And Purpose:
Activation of NMDA subtypes of glutamate receptors is implicated in cell damage induced by ischemia as well as for the establishment of ischemic tolerance after ischemic preconditioning in animal models. We investigated the contributions of NR2A- and NR2B-containing NMDA receptors to ischemic cell death and ischemic tolerance in a rat model of transient global ischemia.
Methods:
Transient global ischemia was produced in rats by 4-vessel occlusion. Neuronal injury was analyzed by Fluoro-Jade B and Nissl staining. Phosphorylation of CREB was detected by Western blotting and immunohistochemistry. In situ hybridization and reverse transcriptase-polymerase chain reaction were used to evaluate the mRNA level of cpg15 and bdnf.
Results:
NR2A subtype-specific antagonist NVP-AAM077 enhanced neuronal death after transient global ischemia and abolished the induction of ischemic tolerance. In contrast, NR2B subtype-specific antagonist ifenprodil attenuated ischemic cell death and enhanced preconditioning-induced neuroprotection. Furthermore, selectively blocking NR2A-, but not NR2B-, containing NMDA receptors inhibited ischemia-induced phosphorylation of CREB and the subsequent upregulation of CREB target genes such as cpg15 and bdnf.
Conclusions:
We found that NR2A- and NR2B-containing NMDA receptor subtypes play differential roles in ischemic neuronal death and ischemic tolerance, suggesting attractive new strategies for the development of drugs for patients with stroke.
Insights
NMDA receptor subtypes NR2A and NR2B have different roles in ischemic stroke. Blocking NR2A worsens injury, while blocking NR2B protects neurons and enhances tolerance, offering new therapeutic strategies.
Area of Science:
- Neuroscience
- Ischemic Stroke Research
- Receptor Pharmacology
Background:
- N-methyl-D-aspartate (NMDA) receptor activation contributes to ischemic cell damage.
- NMDA receptor subtypes are involved in ischemic tolerance following preconditioning.
- Understanding specific NMDA receptor roles is crucial for stroke treatment.
Purpose of the Study:
- Investigate the distinct roles of NR2A- and NR2B-containing NMDA receptors in transient global ischemia.
- Determine their contribution to ischemic cell death and tolerance in a rat model.
- Identify potential therapeutic targets for stroke.
Main Methods:
- Transient global ischemia induced via four-vessel occlusion in rats.
- Neuronal injury assessed using Fluoro-Jade B and Nissl staining.
- Protein and mRNA analysis of CREB phosphorylation, cpg15, and bdnf.
Main Results:
- NR2A antagonist (NVP-AAM077) increased neuronal death and blocked ischemic tolerance.
- NR2B antagonist (ifenprodil) reduced cell death and enhanced neuroprotection.
- Blocking NR2A, but not NR2B, inhibited CREB phosphorylation and target gene upregulation.
Conclusions:
- NR2A and NR2B NMDA receptor subtypes exhibit differential functions in ischemic injury and tolerance.
- Targeting these specific subtypes offers novel therapeutic avenues for stroke patients.
- This research paves the way for developing stroke-specific drugs.
More Related Videos
07:11Examination of Anatomical Features of Retinal Ganglion Cells Under N-methyl-D-aspartic Acid (NMDA)-induced Excitotoxicity
Published on: September 19, 2025
04:48A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
Published on: July 10, 2018
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Cellular Injury IV: Necrosis